895 related articles for article (PubMed ID: 17944743)
41. A small peptide (CEL-1000) derived from the beta-chain of the human major histocompatibility complex class II molecule induces complete protection against malaria in an antigen-independent manner.
Charoenvit Y; Brice GT; Bacon D; Majam V; Williams J; Abot E; Ganeshan H; Sedegah M; Doolan DL; Carucci DJ; Zimmerman DH
Antimicrob Agents Chemother; 2004 Jul; 48(7):2455-63. PubMed ID: 15215094
[TBL] [Abstract][Full Text] [Related]
42. Complete protection against P. berghei malaria upon heterologous prime/boost immunization against circumsporozoite protein employing Salmonella type III secretion system and Bordetella adenylate cyclase toxoid.
Tartz S; Rüssmann H; Kamanova J; Sebo P; Sturm A; Heussler V; Fleischer B; Jacobs T
Vaccine; 2008 Nov; 26(47):5935-43. PubMed ID: 18804138
[TBL] [Abstract][Full Text] [Related]
43. Escheriosome entrapped soluble blood stage antigens impart protective immunity against a multi-drug resistant isolate of Plasmodium yoelii nigeriensis in BALB/c mice.
Sharma SK; Farah D; Misra-Bhattacharya S; Bajpai P; Agarwal A; Mohammad O
Vaccine; 2006 Feb; 24(7):948-56. PubMed ID: 16168527
[TBL] [Abstract][Full Text] [Related]
44. Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogeneous liver memory CD8+ T cells.
Berenzon D; Schwenk RJ; Letellier L; Guebre-Xabier M; Williams J; Krzych U
J Immunol; 2003 Aug; 171(4):2024-34. PubMed ID: 12902507
[TBL] [Abstract][Full Text] [Related]
45. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
Mueller AK; Labaied M; Kappe SH; Matuschewski K
Nature; 2005 Jan; 433(7022):164-7. PubMed ID: 15580261
[TBL] [Abstract][Full Text] [Related]
46. Efficient development of plasmodium liver stage-specific memory CD8+ T cells during the course of blood-stage malarial infection.
Hafalla JC; Rai U; Bernal-Rubio D; Rodriguez A; Zavala F
J Infect Dis; 2007 Dec; 196(12):1827-35. PubMed ID: 18190264
[TBL] [Abstract][Full Text] [Related]
47. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
[TBL] [Abstract][Full Text] [Related]
48. IL-12p40 and IL-18 play pivotal roles in orchestrating the cell-mediated immune response to a poxvirus infection.
Wang Y; Chaudhri G; Jackson RJ; Karupiah G
J Immunol; 2009 Sep; 183(5):3324-31. PubMed ID: 19657092
[TBL] [Abstract][Full Text] [Related]
49. The complexity of protective immunity against liver-stage malaria.
Doolan DL; Hoffman SL
J Immunol; 2000 Aug; 165(3):1453-62. PubMed ID: 10903750
[TBL] [Abstract][Full Text] [Related]
50. Immunity to sporozoite-induced malaria infeciton in mice. I. The effect of immunization of T and B cell-deficient mice.
Chen DH; Tigelaar RE; Weinbaum FI
J Immunol; 1977 Apr; 118(4):1322-7. PubMed ID: 321689
[TBL] [Abstract][Full Text] [Related]
51. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
Dobaño C; Doolan DL
Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
[TBL] [Abstract][Full Text] [Related]
52. A pathogenic role of IL-12 in blood-stage murine malaria lethal strain Plasmodium berghei NK65 infection.
Yoshimoto T; Takahama Y; Wang CR; Yoneto T; Waki S; Nariuchi H
J Immunol; 1998 Jun; 160(11):5500-5. PubMed ID: 9605153
[TBL] [Abstract][Full Text] [Related]
53. Long term protection after immunization with P. berghei sporozoites correlates with sustained IFNγ responses of hepatic CD8+ memory T cells.
Nganou-Makamdop K; van Gemert GJ; Arens T; Hermsen CC; Sauerwein RW
PLoS One; 2012; 7(5):e36508. PubMed ID: 22563506
[TBL] [Abstract][Full Text] [Related]
54. Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells.
Jobe O; Lumsden J; Mueller AK; Williams J; Silva-Rivera H; Kappe SH; Schwenk RJ; Matuschewski K; Krzych U
J Infect Dis; 2007 Aug; 196(4):599-607. PubMed ID: 17624847
[TBL] [Abstract][Full Text] [Related]
55. The role of T cells in pathogenesis and protective immunity to murine malaria.
Waki S; Uehara S; Kanbe K; Ono K; Suzuki M; Nariuchi H
Immunology; 1992 Apr; 75(4):646-51. PubMed ID: 1350570
[TBL] [Abstract][Full Text] [Related]
56. Plasmodium berghei: production and quantitation of hepatic stages derived from irradiated sporozoites in rats and mice.
Scheller LF; Stump KC; Azad AF
J Parasitol; 1995 Feb; 81(1):58-62. PubMed ID: 7876979
[TBL] [Abstract][Full Text] [Related]
57. The role of intrahepatic lymphocytes in mediating protective immunity induced by attenuated Plasmodium berghei sporozoites.
Krzych U; Schwenk R; Guebre-Xabier M; Sun P; Palmer D; White K; Chalom I
Immunol Rev; 2000 Apr; 174():123-34. PubMed ID: 10807512
[TBL] [Abstract][Full Text] [Related]
58. Natural immunization against malaria: causal prophylaxis with antibiotics.
Friesen J; Silvie O; Putrianti ED; Hafalla JC; Matuschewski K; Borrmann S
Sci Transl Med; 2010 Jul; 2(40):40ra49. PubMed ID: 20630856
[TBL] [Abstract][Full Text] [Related]
59. Cross-protection between attenuated Plasmodium berghei and P. yoelii sporozoites.
Sedegah M; Weiss WW; Hoffman SL
Parasite Immunol; 2007 Nov; 29(11):559-65. PubMed ID: 17944745
[TBL] [Abstract][Full Text] [Related]
60. IFN-gamma-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice.
Comes A; Di Carlo E; Musiani P; Rosso O; Meazza R; Chiodoni C; Colombo MP; Ferrini S
Eur J Immunol; 2002 Jul; 32(7):1914-23. PubMed ID: 12115611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
